Seres Therapeutics Inc (NASDAQ: MCRB) Has Slid Negatively For The Year To Date, Predicting What Will Happen Next
Seres Therapeutics Inc (NASDAQ:MCRB)’s traded shares stood at 4.82 million during the last session, with the company’s beta value hitting 2.28. At the close of